Unruptured Intracranial Aneurysm: Medications to Avoid or Use Cautiously

Always consult your neurosurgeon/neurologist before starting/stopping any medication. General principles for unruptured aneurysm management:

Medications Often Avoided or Used With Caution

• Anticoagulants (warfarin, DOACs): ↑ Rupture risk if aneurysm bleeds; balance vs. thromboembolic indication (AF, mechanical valve).
• Antiplatelets (aspirin, clopidogrel): Similar concern; often held pre-procedure; low-dose aspirin may be continued if strong cardiac indication.
• NSAIDs: COX inhibition → impaired platelet function + possible prostaglandin-mediated wall weakening; avoid chronic use.
• Thrombolytics: Contraindicated (catastrophic hemorrhage risk).
• Corticosteroids (high-dose/chronic): Collagen synthesis inhibition → theoretical wall weakening; use lowest effective dose.
• Stimulants (amphetamines, cocaine): ↑ BP, shear stress → rupture risk.

Medications Requiring Individualized Decision

• Statins: Some animal data suggest impaired aneurysm healing; human data conflict. Continue if strong CVD indication.
• Beta-blockers: Historically avoided (↓ collateral flow); newer data support BP control benefit. Individualize.
• Nitroglycerin/nitrates: ↑ Cerebral blood flow, possible ↑ wall stress; use cautiously.
• Hormonal therapy (estrogen): ↑ Coagulability + vascular effects; discuss risks.

Core Principles

1. Strict BP control (target <130/80) — most evidence-based intervention.
2. Smoking cessation (strongest modifiable rupture risk factor).
3. Multidisciplinary team (neurosurgery, neurology, primary care) for shared decision-making.
4. Serial imaging (MRA/CTA) per size/location/growth.